The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Chondrocyte dedifferentiation and osteoarthritis (OA)
Abstract
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage degradation but also synovial membrane inflammation, osteophyte formation and subchondral bone sclerosis. Medical care is mainly based on alleviating pain symptoms, but to date, no effective drug can stop the disease progression. Cartilage is a tissue composed of only one cell type, chondrocytes, wrapped in a collagen rich extracellular matrix they synthesize. Chondrocytes can adopt different phenotypes in vivo and in vitro, defined by the collagen type they produce. Isolated from their matrix, chondrocytes present the particularity to dedifferentiate, producing fibroblastic type I and III collagens. With OA onset, chondrocytes undergo multiple changes, in terms of proliferation, viability, but also secretory profile. The acquisition of a hypertrophic phenotype (producing aberrant type X collagen and catabolic MMP-13 protease) by chondrocytes is well documented and contributes to OA development. However, it is increasingly believed that chondrocytes rather acquire a variety of degenerated phenotypes at the onset of OA, including a "dedifferentiated-like" phenotype that might also contribute to OA progression. In this review, we will (i) present molecular knowledge underlying dedifferentiation process, (ii) emphasize connections between dedifferentiation and OA and (iii) consider OA therapeutic strategies aiming at the maintenance of chondrogenic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Nitric oxide boosts TLR‐4 mediated lipocalin 2 expression in chondrocytes
Gómez, R., Scotece, M., Conde, J., López, V. A. M., Pino, J., Lago, F., Gómez-Reino, J. J., & Gualillo, O. (2013) · Journal of Orthopaedic Research® · doi:10.1002/jor.22331 · Cited by 32
Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury
Chan, D. D., Li, J., Luo, W., Predescu, D. N., Cole, B. J., & Plaas, A. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23635 · Cited by 32
Microsomal Prostaglandin E Synthase-1 in Rheumatic Diseases
Korotkova, M., & Jakobsson, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2010.00146 · Cited by 30
E74‐like factor 3 and nuclear factor‐κB regulate lipocalin‐2 expression in chondrocytes
Conde, J., Otero, M., Scotece, M., Abella, V., López, V., Pino, J., Gómez, R., Lago, F., Goldring, M. B., & Gualillo, O. (2016) · The Journal of Physiology · doi:10.1113/jp272240 · Cited by 30
Chen, W.-H., Lin, C.-M., Huang, C.-F., Hsu, W.-C., Lee, C. H., Ou, K., Dubey, N., & Deng, W.-P. (2016) · American Journal of Sports Medicine · doi:10.1177/0363546516651822 · Cited by 30
Moulin, D., Salone, V., Koufany, M., Clément, T., Behm‐Ansmant, I., Branlant, C., Charpentier, B., & Jouzeau, J. (2017) · BioMed Research International · doi:10.1155/2017/9792512 · Cited by 24
Friedli, K., Almond, M. K., Day, C. J., Chilcot, J., Gane, M. D. S., Davenport, A., Guirguis, A., Fineberg, N. A., Spencer, B. W. J., Wellsted, D. M., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0170-x · Cited by 23
αvβ5 Integrin promotes dedifferentiation of monolayer-cultured articular chondrocytes
Fukui, N., Ikeda, Y., Tanaka, N., Wake, M., Yamaguchi, T., Mitomi, H., Ishida, S., Furukawa, H., Hamada, Y., Miyamoto, Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30351 · Cited by 23
Jones, E., & Schäfer, R. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1785-3_10 · Cited by 23
Zhao, J., Fan, X., Zhang, Q., Sun, F., Li, X., Xiong, C., Zhang, C., & Fan, H. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34711 · Cited by 20
Enhanced cartilage formation by inhibiting cathepsin K expression in chondrocytes expanded in vitro
Zhang, Y., Li, J., Zhu, J. J., Zhou, G., Zhang, W. J., Cao, Y., & Liu, W. X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.070 · Cited by 17
State of art and limitations in genetic engineering to induce stable chondrogenic phenotype
Graceffa, V., Vinatier, C. S., Guicheux, J., Evans, C. H., Stoddart, M. J., Alini, M., & Zeugolis, D. I. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.07.004 · Cited by 17
RHEB: a potential regulator of chondrocyte phenotype for cartilage tissue regeneration
Ashraf, S., Ahn, J., Cha, B.-H., Kim, J.-S., Han, I., Park, H., & Lee, S.-H. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2148 · Cited by 15
Charlier, E., Malaise, O., Zeddou, M., Neuville, S., Cobraiville, G., Deroyer, C., Sanchez, C., Gillet, P., Kurth, W., de Seny, D., et al. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.08.002 · Cited by 14
Self-citationKim, K. M., Kim, J. M., Yoo, Y. H., Kim, J. I., & Park, Y. C. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.892 · Cited by 13
Taipale, M., Jakkula, E., Kämäräinen, O., Gao, P. H., Skarp, S., Barral, S., Kiviranta, I., Kröger, H., Ott, J., Wei, G., et al. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.10.019 · Cited by 12
Proteoglycans synthesized by human chondrocytes cultivated in clusters
Bassleer, C., Gysen, P., Bassleer, R., & Franchimont, P. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90847-3 · Cited by 7
Li, S., Zhang, Y., Sun, Y., Cao, W., & Cui, L. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23605 · Cited by 7
Cited by
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
Zhang, M., Hu, W., Cai, C., Wu, Y., Li, J., & Dong, S. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100223 · Cited by 394
Huang, Y., He, Y., Makarcyzk, M. J., & Lin, H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.677576 · Cited by 53
Metadata
- Authors
- Charlier, E., Deroyer, C., Ciregia, F., Malaise, O., Neuville, S., Plener, Z., Malaise, M., & de Seny, D.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 165
- Pages
- 49-65
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2920832988
- Cited by
- 460
- References
- 218
- FWCI
- 30.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.